Anti-latency agents to purge HIV reservoirs

Anti-latency agents to purge HIV reservoirs

Bibliographic Details
Main Author:	Moreno Santiago
Format:	Article
Language:	English
Published:	BMC 2012-05-01
Series:	Retrovirology

Similar Items

Antagonism of PPARγ for Th17 mucosal immunity restoration and HIV reservoir purging
by: D. Planas, et al.
Published: (2019-12-01)

Current Status of Latency Reversing Agents Facing the Heterogeneity of HIV-1 Cellular and Tissue Reservoirs
by: Amina Ait-Ammar, et al.
Published: (2020-01-01)

Reactivation capacity by latency reversing agents ex vivo correlates with the size of the HIV-1 reservoir
by: Gilles Darcis, et al.
Published: (2016-05-01)

HIV interactions with monocytes and dendritic cells: viral latency and reservoirs
by: Wu Li, et al.
Published: (2009-06-01)

The efficacy and tolerability of latency-reversing agents in reactivating the HIV-1 reservoir in clinical studies: a systematic review
by: Quinten Debrabander, et al.
Published: (2023-09-01)

Impact of IL-15 and latency reversing agent combinations in the reactivation and NK cell-mediated suppression of the HIV reservoir
by: Daniela Angela Covino, et al.
Published: (2022-11-01)

Patient-derived HIV reservoirs can be stably engrafted into NSG mice and reactivated by latency-reversing agents in vivo
by: A. Ward, et al.
Published: (2017-12-01)

O6 Reactivation capacity by latency reversing agents ex vivo correlates with the size of the HIV-1 reservoir
by: Gilles Darcis, et al.
Published: (2016-09-01)

HIV-1 Latency and Viral Reservoirs: Existing Reversal Approaches and Potential Technologies, Targets, and Pathways Involved in HIV Latency Studies
by: Sushant Khanal, et al.
Published: (2021-02-01)

HIV Latency and Nanomedicine Strategies for Anti-HIV Treatment and Eradication
by: Mickensone Andre, et al.
Published: (2023-02-01)

23 Understanding the effects of latency reversing agents on HIV RNA splicing: implications for latency reversal
by: T.M. Mota, et al.
Published: (2016-07-01)

21 Patient-derived HIV reservoirs can be stably engrafted into NSG mice and reactivated by latency-reversing agents in vivo
by: Adam Ward, et al.
Published: (2017-07-01)

Optimisation of Smac mimetics as HIV-1 latency reversing agents
by: L. Pache, et al.
Published: (2019-12-01)

Latency reversal plus natural killer cells diminish HIV reservoir in vivo
by: Jocelyn T. Kim, et al.
Published: (2022-01-01)

Elimination of HIV-1-Infected Primary T Cell Reservoirs in an In Vitro Model of Latency.
by: Stephen A Rawlings, et al.
Published: (2015-01-01)

Low viral reservoir treated individuals show unusual HIV latency distribution
by: C. Gálvez, et al.
Published: (2019-12-01)

Philip Kitcher’s purge of philosophy
by: Williamson, T
Published: (2024)

Dental aspects of purging bulimia
by: Manevski Jovana, et al.
Published: (2020-01-01)

Combinatorial latency reversal activity of inhibitor of apoptosis antagonists with mechanistically distinct classes of HIV latency reversal agents
by: Shane D. Falcinelli, et al.
Published: (2019-12-01)

Optimal Control of an HIV Model with Gene Therapy and Latency Reversing Agents
by: Zachary Abernathy, et al.
Published: (2021-11-01)

Latency reversal agents affect differently the latent reservoir present in distinct CD4+ T subpopulations.
by: Judith Grau-Expósito, et al.
Published: (2019-08-01)

The Effect of JAK1/2 Inhibitors on HIV Reservoir Using Primary Lymphoid Cell Model of HIV Latency
by: Lesley R. de Armas, et al.
Published: (2021-08-01)

Military purges and the recurrence of civil conflict
by: Jessica Maves Braithwaite, et al.
Published: (2016-02-01)

Membrane gas separation with permeate purging /
by: 324683 Li, K., et al.

Root pass welding and gas purging
by: 8940 American Welding Society

Differential effects of HIV latency-reversing agents on T cell phenotype and function: implications for HIV cure
by: G. Clutton, et al.
Published: (2015-12-01)

Hormonal control of HIV-1 latency by estrogen imparts gender-specific restrictions on the latent reservoir
by: J. Karn, et al.
Published: (2019-07-01)

HIV latency reversing agents act through Tat post translational modifications
by: Georges Khoury, et al.
Published: (2018-05-01)

Novel use of alprazolam as a potential HIV-1 latency reversing agent
by: W. Elbezanti, et al.
Published: (2017-12-01)

Diverse Impacts of HIV Latency-Reversing Agents on CD8+ T-Cell Function: Implications for HIV Cure
by: Genevieve Tyndale Clutton, et al.
Published: (2018-06-01)

On the Possibility of a General Purge of Self-Reference
by: Lucas Rosenblatt
Published: (2012-05-01)

Design And Development Of Gas Argon Purging System
by: Ooi, Seng Yeong
Published: (2006)

On the Consequences of Purging and Linkage on Fitness and Genetic Diversity
by: Diego Bersabé, et al.
Published: (2016-01-01)

The pro-Franco purge of the primary teaching profession
by: Juan Manuel FERNÁNDEZ SORIA, et al.
Published: (2013-11-01)

Electroosmotic purging of contaminants from saturated soils
by: Shapiro, Andrew P
Published: (2005)

New Concepts in Therapeutic Manipulation of HIV-1 Transcription and Latency: Latency Reversal versus Latency Prevention
by: Catherine A. Lewis, et al.
Published: (2023-07-01)

Discovering the Mechanisms of Oleodaphnone as a Potential HIV Latency-Reversing Agent by Transcriptome Profiling
by: Shifei Li, et al.
Published: (2023-04-01)

Molecular Modeling and Synthesis of New HIV Latency-Reversing Agents Targeting the Lymphatic System
by: Beatriz Meduqui Rodrigues, et al.
Published: (2022-11-01)

Epigenetic Regulation of HIV-1 Sense and Antisense Transcription in Response to Latency-Reversing Agents
by: Rui Li, et al.
Published: (2023-01-01)

OP 2.8 – 00193 Enhancing PKC Modulator HIV Latency Reversing Agents
by: M. Marsden, et al.
Published: (2022-12-01)